These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2507405)

  • 1. Nocturnal myoclonus in restless legs syndrome effect of carbamazepine treatment.
    Zucconi M; Coccagna G; Petronelli R; Gerardi R; Mondini S; Cirignotta F
    Funct Neurol; 1989; 4(3):263-71. PubMed ID: 2507405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nocturnal myoclonus and restless legs syndrome.
    Lugaresi E; Cirignotta F; Coccagna G; Montagna P
    Adv Neurol; 1986; 43():295-307. PubMed ID: 3946114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of periodic leg movements and severity of restless legs syndrome: a study in unmedicated and medicated patients.
    Hornyak M; Hundemer HP; Quail D; Riemann D; Voderholzer U; Trenkwalder C
    Clin Neurophysiol; 2007 Jul; 118(7):1532-7. PubMed ID: 17531532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Night-to-night variability in periodic leg movements in patients with restless legs syndrome.
    Sforza E; Haba-Rubio J
    Sleep Med; 2005 May; 6(3):259-67. PubMed ID: 15854857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodic limb movement disorder and restless legs syndrome in dialysis patients.
    Rijsman RM; de Weerd AW; Stam CJ; Kerkhof GA; Rosman JB
    Nephrology (Carlton); 2004 Dec; 9(6):353-61. PubMed ID: 15663636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propriospinal myoclonus: a motor phenomenon found in restless legs syndrome different from periodic limb movements during sleep.
    Vetrugno R; Provini F; Plazzi G; Cortelli P; Montagna P
    Mov Disord; 2005 Oct; 20(10):1323-9. PubMed ID: 16007657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome.
    Wetter TC; Stiasny K; Kohnen R; Oertel WH; Trenkwalder C
    Mov Disord; 1998 Sep; 13(5):820-4. PubMed ID: 9756152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].
    Imamura A; Tsuboi Y; Tanaka M; Obata T; Yamada T
    Rinsho Shinkeigaku; 2007 Apr; 47(4):156-9. PubMed ID: 17511286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of periodic leg movements and associated transcranial magnetic stimulation parameters in restless legs syndrome.
    Kutukcu Y; Dogruer E; Yetkin S; Ozgen F; Vural O; Aydin H
    Muscle Nerve; 2006 Jan; 33(1):133-7. PubMed ID: 16175624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review and videotape recognition of idiopathic restless legs syndrome.
    Walters AS; Hening WA; Chokroverty S
    Mov Disord; 1991; 6(2):105-10. PubMed ID: 1676135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restless legs syndrome in end-stage renal disease.
    Gigli GL; Adorati M; Dolso P; Piani A; Valente M; Brotini S; Budai R
    Sleep Med; 2004 May; 5(3):309-15. PubMed ID: 15165541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S; Wetter TC
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of recalcitrant restless legs syndrome with botulinum toxin type-A.
    Rotenberg JS; Canard K; Difazio M
    J Clin Sleep Med; 2006 Jul; 2(3):275-8. PubMed ID: 17561538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between putative indicators of primary restless legs syndrome severity.
    Aksu M; Demirci S; Bara-Jimenez W
    Sleep Med; 2007 Jan; 8(1):84-9. PubMed ID: 16740410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment.
    Kallweit U; Siccoli MM; Poryazova R; Werth E; Bassetti CL
    Eur Neurol; 2009; 62(3):176-9. PubMed ID: 19602890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectral analysis of sleep EEG in patients with restless legs syndrome.
    Hornyak M; Feige B; Voderholzer U; Riemann D
    Clin Neurophysiol; 2005 Jun; 116(6):1265-72. PubMed ID: 15978488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
    García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
    Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
    Walters AS; Ondo WG; Dreykluft T; Grunstein R; Lee D; Sethi K;
    Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
    Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of an algorithm for the diagnosis of Restless Legs Syndrome: The Restless Legs Syndrome-Diagnostic Index (RLS-DI).
    Benes H; Kohnen R
    Sleep Med; 2009 May; 10(5):515-23. PubMed ID: 18823819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.